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ABSTR AC T

Background and study aims The use of lumen apposing
metal stents (LAMS) during EUS-guided transmural drainage (EUS-TD) of pancreatic walled-off necrosis (WON) has
gained popularity. Data supporting their use in WON over
plastic stents (PS), however, remain scarce. The aim of this
study was to compare the clinical efficacy of LAMS (Axios,
Boston Scientific) with PS in WON.
Patients and methods This was a multicenter, retrospective study involving 14 centers. Consecutive patients who
underwent EUS-TD of WON (2012 – 2016) were included.
The primary end point was clinical success defined as WON
size ≤ 3 cm within a 6-month period without need for percutaneous drainage (PCD) or surgery.
Results A total of 189 patients (mean age 55.2 ± 15.6
years, 34.9 % female) were included (102 LAMS and 87 PS).
Technical success rates were similar: 100 % in LAMS and
98.9 % in PS (P = 0.28). Clinical success was attained in
80.4 % of LAMS and 57.5 % of PS (P = 0.001). Rate of PCD
was similar (13.7 % LAMS vs. 16.3 % PS, P = 0.62), while PS
was associated with a greater need for surgery (16.1 % PS
vs. 5.6 % LAMS, P = 0.02). Adverse events (AEs) were observed in 9.8 % of LAMS and 10.3 % of PS (P = 0.90) and
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Conclusions When compared to PS, LAMS in WON is associated with higher clinical success, shorter procedure time,
lower need for surgery, and lower rate of recurrence.

Introduction

Materials and methods

Acute necrotizing pancreatitis occurs in up to 20 – 40 % of acute
pancreatitis [1, 2]. Pancreatic parenchymal or extraparenchymal necrosis can lead to tissue liquefaction and subsequent organization with a thin rim of granulation tissue otherwise
known as pancreatic walled-off necrosis (WON). WON can be
associated with substantial morbidity and mortality, especially
when infected [2 – 5]. Although generally asymptomatic, WON
can result in abdominal pain, early satiety, gastric outlet and
biliary obstruction, vascular occlusion, fistula formation, and
the development of pseudoaneurysm and bleeding. Traditionally, WON has been managed surgically; however, surgical necrosectomy is associated with substantial morbidity and mortality, particularly when pursued early [6, 7]. More recently, a
step-up approach consisting of a minimally invasive modality,
such as percutaneous (PCD) or endoscopic drainage has been
shown to decrease morbidity and mortality, and is advocated
over surgery as first-line treatment by consensus guidelines
[5, 6]. A peroral endoscopic approach has gained popularity
with the advent of therapeutic EUS and the development of novel stents that allow for drainage and direct endoscopic necrosectomy (DEN) [8, 9].
Generally, endoscopic drainage of WON is performed with
plastic stents. These stents, however, are limited by their small
diameter leading to increased risk of stent obstruction [10 –
13]. While studies using a combination of plastic stents and
PCD for the drainage of WON have shown high clinical success
rates [14, 15], the same day integrated delivery of these interventions is not feasible for most centers. Recently, lumen-apposing metal stents (LAMS) have been introduced for the management of pancreatic fluid collections (PFC), including WON
[16]. The main advantages of LAMS include their large diameters that allow for greater drainage and permit DEN, while the
bi-flanged design prevents stent migration. LAMS placement
for PFCs is associated with excellent outcomes; however, most
studies have included both pseudocysts and WON, which have
vastly different natural histories and response to management
[17 – 21]. In addition, comparative data for LAMS vs. plastic
stents (PS) specifically for treatment of WON are scarce.
There are currently three types of LAMS on the market,
namely the Axios (Boston Scientific, Marlborough, MA, United
States), Nagi, and Spaxus (Taewoong, Medical, Ilsan, South Korea) stents. The goal of this large international retrospective
study was to compare the clinical outcome of endoscopically
placed LAMS (Axios) with plastic stents in the management of
WON. The Nagi and Spaxus stents were not included given their
unavailability in the USA.

This is an international, multicenter retrospective study involving 14 centers (12 in North America, 2 in Europe). Consecutive
patients who underwent EUS-guided WON drainage with either
LAMS or PS between January 2012 and August 2016 were included. A total of 17 patients included in this study who underwent insertion of LAMS for WON were reported in a previous
publication [27]. WON was defined as per the Atlanta classification as an organized collection with both liquid and necrotic solid components (on CT, MRI, and/or EUS) developing approximately 4 weeks post-acute pancreatitis [22]. Patients with pancreatic pseudocysts, defined as an organized collection without
solid components developing 4 weeks post-acute pancreatitis
[22], and patients with less than 30 days follow-up were excluded. The institutional review board at each center approved this
study.
Patients were identified using center-specific endoscopic or
billing databases. Electronic chart reviews were performed to
capture variables such as demographics, WON location, size,
percentage of necrosis, extension into the paracolic gutter,
presence of main pancreatic duct disruption or leak based on
endoscopic retrograde cholangiopancreatography (ERCP) findings, etiology of pancreatitis, indication for drainage, stent
type, size, and number, drainage approach (transgastric, transduodenal, transesophageal), technical success, procedure
time, need for DEN, number of DEN sessions (if required), use
of hydrogen peroxide irrigation, insertion of nasocystic tubes,
need for percutaneous drainage (PCD), size of PCD, clinical success, successful stent removal following clinical success, ERCP
performed within 30 days pre- or post-index procedure and insertion of transpapillary pancreatic stents, stent obstruction,
stent migration with stent displacement confirmed via endoscopy, WON recurrence, need for surgery, adverse events with
severity graded according to the ASGE lexicon [23], length of
hospitalization, and total follow-up time in days.

E348

Drainage of walled-off pancreatic necrosis with the
lumen apposing metal stent
As per standard practice, written informed consent was obtained from all patients before the procedure. Prophylactic antibiotics were administered peri-procedurally per institutional protocol. A linear echoendoscope was then inserted to first assess
the location, size, and amount of necrosis. Color Doppler was
then used to assess surrounding vascular structures. The distance between the EUS-probe and WON was then ascertained
and drainage performed only if it was < 1 cm. LAMS insertion
with cautery assistance into the WON cavity was followed by
deployment of the distal flange then the proximal flange under
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were rated as severe in 2.0 % and 6.9 %, respectively (P =
0.93). After excluding patients with < 6 months follow-up,
the rate of WON recurrence following initial clinical success
was greater with PS (22.9 % PS vs. 5.6 % LAMS, P = 0.04).

Drainage of walled-off pancreatic necrosis with
plastic stents
Following the appropriate peri-procedural care as described
above, the WON was assessed with a linear echoendoscope
and the cavity punctured with a 19-gauge fine-needle aspiration (FNA) needle from the stomach or duodenum. A 0.025 –
0.035 inch guidewire was then inserted and coiled inside the
WON cavity under fluoroscopic guidance. Tract dilation was
then performed either with cystotome or radial expansion balloon to facilitate stent placement. Double pigtail plastic stents
were inserted over the wire under fluoroscopic guidance. The
number and size of stents used were at the discretion of the
endoscopist. When required, DEN was performed once the cystogastrostomy/duodenostomy tract had matured. This was
done by first removing the stents followed by dilation of the
tract with a radial expansion balloon and insertion of a forward
viewing gastroscope through the tract for DEN. Plastic stents
were then placed after completion of the necrosectomy. The
use of nasocystic tube drainage and/or hydrogen peroxide irrigation was at the discretion of the endoscopist.

identified for standard stepwise logistic regression analysis.
These included age, gender, WON location, WON size, percent
necrosis, extension of WON into paracolic gutter, etiology of
pancreatitis, stent type (LAMS vs. PS), drainage approach
(transgastric vs. transduodenal), endoscopic necrosectomy
performed, use of hydrogen peroxide irrigation, ERCP performed < 30 days after drainage, and presence of pancreatic
duct disruption. Variables with a P value of less than 0.25 in
the univariable analysis were carried forward into the multivariable analysis.

Results
A total of 189 patients (mean age 55 ± 16 years, 34.9 % female)
were identified with 102 cases of LAMS and 87 cases of PS
(▶ Table 1). Etiologies of acute pancreatitis were 42.0 % gallstone pancreatitis, 30.3 % idiopathic, 22.3 % alcohol induced,
3.7 % post ERCP, 1.1 % trauma, and 0.5 % autoimmune (▶ Table 2). Primary indications for drainage were abdominal pain in
49.5 %, infected WON in 26.6 %, gastric outlet obstruction in
12.2 %, early satiety in 5.9 %, rapid increase in WON size in
3.7 %, biliary obstruction in 1.1 %, and other causes in 1.1 %.
WON was located at the head in 17.1 %, the body in 66.3 %, the
tail in 11.8 %, involving the entire pancreas in 4.3 %, and extrapancreatic in 0.5 %. The mean diameter was 120.9 ± 51.4 mm.
Percent necrosis as estimated on CT scan or MRI (available in
149 patients) was 0 – 25 % in 33 patients, 25 – 50 % in 52 patients, 50 – 75 % in 41 patients, and > 75 % in 23 patients.
Paracolic gutter extension was noted in 30.7 % LAMS and
39.5 % PS (P = 0.21), while disconnected pancreatic duct, as di-

End points

▶ Table 1 Distribution of data by center and stent type.
Center

LAMS

PS

Total

1

20

6

26

2

8

4

12

3

8

18

26

4

4

5

9

5

9

10

19

6

3

1

4

7

26

0

26

8

4

17

21

The primary end point was the rate of clinical success defined as
symptom resolution and decrease in size of the WON to ≤ 3 cm
in diameter within 6 months without the need for PCD or surgery. Secondary end points included rate of technical success,
adverse events with severity graded per the ASGE Lexicon
[23], stent dysfunction due to migration or occlusion, WON recurrence (defined as recurrent symptoms and increase in WON
diameter > 3 cm), and need for surgery defined as any surgical
intervention (minimally invasive or open) for the management
of unresolved WON or complications arising from endoscopic
or percutaneous drainage.

9

1

5

6

10

5

2

7

Statistical analysis

11

2

8

10

Continuous variables were reported as mean ± standard deviation (or median and range, where appropriate). Categorical
variables were reported as proportions and 95 %CIs, with inferential analysis performed using chi-squared testing. A level of
significance of P < 0.05 was adopted for all inferential testing. A
total of 13 independent variables considered to be clinically relevant by the investigators in predicting clinic success were

12

2

3

5

13

2

0

2

14

8

8

16

102

87

189
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EUS or endoscopic guidance. If a non-cautery assisted LAMS
was used, then the WON was first punctured with a 19-gauge
needle followed by coiling of 0.025 or 0.035 inch guidewire in
the WON under fluoroscopic guidance, tract dilation, and insertion of the LAMS. At the discretion of the endoscopist, the stent
could then be dilated to the desired size with a wire guided radial expansion balloon. Direct endoscopic necrosectomy could
then be performed at the index procedure or more commonly
during a subsequent procedure. DEN was performed through
the LAMS with a forward viewing gastroscope. Necrotic tissue
was then debrided using various accessories. Irrigation of the
WON cavity with dilute hydrogen peroxide and insertion of a
nasocystic tube was performed at the discretion of the endoscopist.

Original article

▶ Table 2 Baseline demographic and walled-off pancreatic necrosis characteristics.
LAMS (n = 102)

PS (n = 87)

P value

Age, mean ± SD, years

54 ± 16

57 ± 15

0.213

Female gender, %

53.0

47.0

0.850
0.497

▪ Gallstone pancreatitis

42.6

41.4

▪ Idiopathic

17.8

20.7

▪ Alcohol induced

26.7

17.2

▪ Post ERCP

3.0

4.6

▪ Trauma

1.0

1.1

▪ Autoimmune

1.0

0

WON location, %

0.249

▪ Head

18.8

15.1

▪ Body

66.3

66.3

▪ Tail

7.9

16.3

▪ Entire pancreas

5.9

2.3

▪ Extrapancreatic

1.0

0

WON size, mm

111.4 ± 43.6

135.0 ± 58.1

Percent necrosis, %

0.213
0.190

▪ 0 – 25 %

16.0

29.4

▪ 25 – 50 %

40.7

27.9

▪ 50 – 75 %

27.2

27.9

▪ 75 – 100 %

16.0

14.7

Paracolic gutter extension, %

30.7

39.5

0.206

Disconnected duct, %

15.8

31.4

0.114

ERCP, endoscopic retrograde cholangiopancreatography; LAMS, Lumen apposing metal stent; PS, plastic stent; WON, walled-off necrosis.

agnosed on ERCP performed in 73 patients, was seen in 15.8 %
LAMS and 31.4 % PS (P = 0.11) ( ▶ Table 2). Percent necrosis was
also comparable between the two groups with 54.7 % of LAMS
and 45.3 % of PS having > 50 % necrosis.

Procedure characteristics
Transgastric stenting was the most common approach in both
cohorts (95.1 % LAMS vs. 92.0 % PS, P = 0.462) ( ▶ Table 3). Procedure time was significantly shorter with LAMS (50.4 ± 26.5
minutes vs. 64.6 ± 34.0 minutes, P = 0.003). DEN was more frequently performed in the LAMS group (81.4 % LAMS vs. 48.4 %
PS, P < 0.001). In patients who underwent DEN, the mean numbers of sessions were 1.9 ± 1.4 in LAMS and 2.6 ± 2.9 in PS (P =
0.09). Hydrogen peroxide irrigation was undertaken in 51.0 %
and 4.6 % of patients with LAMS and PS, respectively (P <
0.001), while nasocystic drain insertion was comparable between the two groups (3.9 % LAMS vs. 6.9 % PS, P = 0.36). The
total number of endoscopic procedures before stent removal
was similar between the two groups (2.6 ± 1.5 LAMS vs. 3.1 ±

E350

1.5 PS, P = 0.129). ERCP was performed in 34.3 % LAMS and
41.4 % PS (P = 0.32), with main pancreatic duct stent insertion
in 18.6 % LAMS and 27.6 % PS (P = 0.14). Pancreatic stent was
deemed to have bridged the pancreatic duct leak in 56.3 % and
36.4 % in LAMS and PS, respectively (P = 0.22).

Clinical end points and adverse events
Technical success was achieved in 100.0 % of procedures in the
LAMS group compared to 98.9 % of procedures in the PS group
(P = 0.28) (▶ Table 4). Post-procedural mean length of stay was
not significantly different between the two groups (10.4 ± 27.1
days for LAMS vs. 10.2 ± 16.4 days for PS, P = 0.93). Clinical success was attained in 80.4 % of LAMS patients compared to
57.5 % of PS patients (P = 0.001). The need for percutaneous
drainage was similar between the two groups (13.7 % LAMS vs.
16.3 % P = 0.624), while the use of PS was associated with significantly greater need for surgery (16.1 % PS vs. 5.6 % LAMS, P =
0.023).
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Etiology of pancreatitis, %

▶ Table 3 Procedure characteristics.
LAMS (n = 102)

PS (n = 87)

▪ Transgastric

0.462
95.1

92.0

▪ Transduodenal

4.9

6.9

▪ Transesophageal

0

1.1

Number of stents

1.07 ± 0.3

2.3 ± 0.8

< 0.001

Total mean stent diameter, mm

14.8

7.7

< 0.001

DEN performed, %

81.4

48.4

< 0.001

Mean number of DEN
Hydrogen peroxide irrigation, %

1.9 ± 1.4

2.6 ± 2.9

0.09

51.0

4.6

< 0.001

Nasocystic drain, %

3.9

6.9

0.362

Total number of endoscopic procedures

2.6 ± 1.5

3.1 ± 1.5

0.129

ERCP performed, %

34.3

41.4

0.317

Transpapillary pancreatic stent, %

18.6

27.6

0.143

Pancreatic stent bridges site of leak, %

56.3

36.4

0.224

ERCP, endoscopic retrograde cholangiopancreatography; LAMS, lumen apposing metal stent; PS, plastic stent; DEN, direct endoscopic necrosectomy.

▶ Table 4 Clinical outcomes.
LAMS (n = 102)

PS (n = 87)

P value

100.0

98.9

0.276

Clinical success, %

80.4

57.5

0.001

Post procedure length of stay, days

10.4

10.2

0.930

Percutaneous drain, %

13.7

16.3

0.624

5.6

16.1

0.023

5.6

22.9

0.036

Technical success, %

Surgical intervention, %
1

Recurrenc , %

LAMS, Lumen apposing metal stent; PS, plastic stent.
1
After excluding patients with less than 6 months follow-up (total of 74 patients excluded: 52 LAMS and 22 PS).

A total of 19 adverse events were observed with an overall
adverse event rate of 10.1 %. The rate of AEs was comparable
between the two groups (9.8 % LAMS and 10.3 % PS, P = 0.90).
Adverse events included bleeding (n = 10), peritonitis (n = 4),
stent misdeployment (n = 1), perforation (n = 2), and other (n =
2). In terms of severity, 26.3 % were rated as mild, 31.6 % moderate, and 42.1 % severe. The rate of severe adverse events was
2.0 % for LAMS and 6.9 % for PS (P = 0.93). In terms of stent dysfunction, migration occurred in 2.9 % LAMS and 6.9 % PS (P =
0.20), while stent occlusion occurred in 20.6 % LAMS vs. 12.6 %
PS (P = 0.15). In those who achieved clinical success, the use of
PS was associated with higher rates of WON recurrence (24.0 %
PS vs. 2.4 % LAMS, P < 0.001). When excluding all patients with
< 6 months follow-up, recurrence rates remained higher in the
PS cohort (22.9 % PS vs. 5.6 % LAMS, P = 0.04) (▶ Table 4). Stent
removal following clinical resolution was successful in all patients who were not lost to follow-up. The median length of fol-

low-up was 144 days (IQR 87.8 – 200.25 days) for LAMS and 436
days (IQR 147 – 725 days) for PS.

Predictors of clinical success
Univariable analysis of the aforementioned variables identified
the following factors as predictors of clinical success: size of
the WON (P = 0.004), WON extension into the paracolic gutter
(P < 0.001), stent type/LAMS vs. PS (P = 0.001), hydrogen peroxide irrigation (P = 0.02), and ERCP performed < 30 days after
WON drainage (P = 0.03). On multivariable analysis, the use of
LAMS (OR 3.2, 95 %CI: 1.3 – 8.0, P = 0.01) and the performance
of ERCP < 30 days after drainage (OR 3.4, 95 %CI: 1.3 – 8.9, P =
0.01) were identified as independent positive predictors of clinical success while the presence of paracolic gutter WON extension (OR 0.3, 95 %CI: 0.1 – 0.7, P = 0.006) was an independent
negative predictor of clinical success ( ▶ Table 5).
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Drainage approach, %

P value

▶ Table 5 Multivariable analysis for predictors of clinical success.
Variables

OR, 95 %CI

P value

LAMS vs. PS

3.2, 1.3 – 8.0

0.01

ERCP performed < 30 days post
drainage

3.4, 1.3 – 8.9

0.01

Paracolic gutter extension

0.3, 0.1 – 0.7

0.006

WON size

1.0, 0.996 – 1.01

0.3

Hydrogen peroxide irrigation

2.2, 0.7 – 6.6

0.2

Age

1.0, 0.992 – 1.05

0.2

ERCP, endoscopic retrograde cholangiopancreatography; LAMS, Lumen apposing metal stent; PS, plastic stent; WON, walled-off necrosis.

Discussion
With the advent of LAMS and data supporting a minimally invasive step-up approach to WON over the surgical method [5, 8],
endoscopic management of pancreatic fluid collections has
gained popularity. In this international multicenter retrospective study, we demonstrate that the use of LAMS for treatment
of WON is associated with higher clinical success (80.4 % vs.
57.5 % P = 0.001), shorter procedure time (50.4 minutes vs.
64.6 minutes), lower requirements for surgery (5.6 % vs.
16.1 %), lower WON recurrence following clinical success
(22.9 % vs. 5.6 %), and similar rates of AEs (9.8 % vs. 10.3 %)
when compared to PS.
The rates of clinical success in both LAMS (80.4 %) and PS
(57.5 %) groups are in keeping with the current literature [11,
18, 20, 21, 24 – 29]. In the largest series of LAMS placement for
WON, clinical success was achieved in 86.3 % of 124 patients,
while in a study involving 211 patients who underwent PS insertion, the clinical success rate was 63.2 % [27, 29]. Unlike pancreatic pseudocysts, the main challenge in WON treatment is removal of solid necrotic components of the collection. Several
advantages of LAMS include their large diameters and anti-migration properties. Interestingly, however, despite the larger

stent diameter, stent occlusion was frequent in LAMS occurring
in 20.6 % of cases. The larger diameter likely allows a greater
amount of solid debris to drain spontaneously; however, this
also means that large solid components can build up within
the stent leading to occlusion. Some experts have advocated
the insertion of a double pigtail plastic stent through the
LAMS or insertion of multiple LAMS (multigateway drainage) in
order to minimize occlusion (▶ Fig. 1). Indeed, a small comparative retrospective study has suggested that the addition of
a double pigtail plastic stent through the LAMS may be associated with fewer adverse events [30].
Another potential advantage of LAMS is its ability to facilitate additional modalities of treatment including direct endoscopic necrosectomy and hydrogen peroxide irrigation. In fact,
the rates of both DEN and hydrogen peroxide irrigation were
significantly greater in patients who underwent drainage with
LAMS in our study. The performance of DEN has been shown
to lead to higher rates of successful WON resolution than drainage alone and is associated with a lower need for administration
of antibiotics, shorter length of hospital stay, and lower health
care utilization [24, 31]. However, with the use of PS, DEN is difficult and cumbersome requiring stent removal and tract dilation leading to higher rates of AEs, up to 14 – 26 % and even
mortality in up to 7.5 % of cases [24, 32]. LAMS, on the other
hand, allows for DEN to be performed through the stent without the risk associated with stent removal and tract dilation. In
a large retrospective series of 78 patients undergoing DEN following LAMS insertion, the AE rate was 6.4 % with three cases of
stent migration, all of which were replaced without sequela,
and two cases of bleeding controlled with interventional radiology embolization [27]. The large diameter of the LAMS also facilitates irrigation with dilute hydrogen peroxide, which may
enhance breakdown of solid necrotic debris [33, 34]. Although
these adjuvant modalities probably play an important role in
the management of WON, our multivariable analysis identified
the use of LAMS as an independent predictor of clinical success
while both DEN and hydrogen peroxide irrigation were not significant predictors.

▶ Fig. 1 Multigateway drainage with insertion of two lumen apposing stents with additional plastic stents to prevent stent obstruction. a EUS
image of a large pancreatic walled-off necrosis with extensive solid components. b Successful deployment of a lumen apposing stent forming
a cystogastrostomy. c Two lumen apposing stents inserted with plastic double pigtail stents in situ.
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the PS cohort was significantly longer than in the LAMS group,
which may have contributed to the higher WON recurrence and
surgery rates seen in the PS group. However, even after excluding patients with less than 6 months follow-up from the LAMS
cohort, our conclusion remained the same. Our data also suggest a shorter procedure time with LAMS; however, it is important to keep in mind that a standardized timekeeper was not
available given the retrospective nature of this study and procedure time was defined as starting from insertion of the endoscope to removal of the endoscope and may not have accounted for additional procedures such as ERCP therefore limiting the
robustness of this end point. Lastly, our results only apply to the
Axios stent and cannot be generalized to other LAMS such as
the Nagi and Spaxus stents. Strengths of our study include its
multicenter design, large number of patients, and exclusion of
patients with pseudocysts. It also provides comprehensive data
on the different clinical and procedural factors that could influence outcomes including percent necrosis of the WON, presence of extension in the paracolic gutter, and whether or not
concomitant ERCP was performed.
In conclusion, our data indicate that, when compared to PS,
the use of LAMS in endoscopic drainage of WON is associated
with higher clinical success, shorter procedure time, lower
need for surgery, and lower rate of recurrence with a comparable rate of AE. Prospective controlled trials are now needed to
confirm our findings.
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